LEIDOS BIOMEDICAL RESEARCH INC - IND-DIRECTED DEVELOPMENT OF ANTIVIRAL THERAPIES TO COMBAT DISEASES OF PANDEMIC POTENTIAL

On Dec 1, 2025, Department of Health and Human Services obligated $16,869,382 to LEIDOS BIOMEDICAL RESEARCH INC for ind-directed development of antiviral therapies to combat diseases of pandemic potential. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Jul 26, 2027 — approximately 14 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.